Jefferies Financial Group Analysts Give Fresenius Medical Care AG & Co. KGaA (ETR:FME) a €21.00 Price Target

Jefferies Financial Group set a €21.00 ($22.58) price objective on Fresenius Medical Care AG & Co. KGaA (ETR:FME – Get Rating) in a report published on Tuesday, Borsen Zeitung reports.

FME has been the topic of several other reports. JPMorgan Chase & Co. set a €17.10 ($18.39) target price on shares of Fresenius Medical Care AG & Co. KGaA in a report on Monday, February 20th. Deutsche Bank Aktiengesellschaft set a €23.00 ($24.73) target price on shares of Fresenius Medical Care AG & Co. KGaA in a report on Thursday, March 9th. Warburg Research set a €22.00 ($23.66) target price on shares of Fresenius Medical Care AG & Co. KGaA in a report on Monday, March 6th. Credit Suisse Group set a €35.00 ($37.63) price objective on shares of Fresenius Medical Care AG & Co. KGaA in a report on Tuesday. Finally, Berenberg Bank set a €46.83 ($50.35) price objective on shares of Fresenius Medical Care AG & Co. KGaA in a report on Wednesday, March 8th.

Fresenius Medical Care AG & Co. KGaA Stock Performance

Shares of FME stock opened at €37.35 ($40.16) on Tuesday. The company has a debt-to-equity ratio of 85.52, a quick ratio of 0.80 and a current ratio of 1.27. The company has a market capitalization of $10.96 billion, a P/E ratio of 16.20, a price-to-earnings-growth ratio of 1.02 and a beta of 0.88. The company’s 50 day moving average price is €34.86 and its two-hundred day moving average price is €31.82. Fresenius Medical Care AG & Co. KGaA has a 52 week low of €25.95 ($27.90) and a 52 week high of €63.60 ($68.39).

Fresenius Medical Care AG & Co. KGaA Company Profile

(Get Rating)

Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.